FDA Inspection 1029456 — KRS Global Biotechnology, Inc

KRS Global Biotechnology, Inc — FEI 3006412304

The FDA completed an inspection of KRS Global Biotechnology, Inc on Oct 23, 2017 in Boca Raton, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 23, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boca Raton, FL (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
188521 CFR 211.165(b)Microbiological testing
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.